| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.9M | -38.8% |
| Cost of Revenue | $6.4M | -37.2% |
| Gross Profit | $542K | -52.7% |
| R&D Expense | $76K | -76.1% |
| SG&A Expense | $3.1M | -33.9% |
| Operating Income | -$3.0M | +48.4% |
| Pre-tax Income | -$2.9M | +47.0% |
| Net Income | -$2.9M | +47.0% |
| EPS (Basic) | -$0.36 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.5M | -32.9% |
| Accounts Receivable | $19K | +604.2% |
| Inventory | $296K | -14.9% |
| Current Assets | $13.4M | -34.8% |
| Total Assets | $13.8M | -34.5% |
| Current Liabilities | $1.3M | -78.3% |
| Total Liabilities | $1.5M | -75.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | -92.2% |
| Capital Expenditures | $30K | +0.0% |
| Investing Cash Flow | $200 | +100.7% |
| Financing Cash Flow | $19.7M | +0.0% |
| Free Cash Flow | -$6.2M | -91.3% |
| +57.1% |
| EPS (Diluted) | -$0.36 | +57.1% |
| Stockholders' Equity |
| $12.3M |
| -17.7% |